Lineage Cell Therapeutics, Inc. earnings per share and revenue

LCTX earnings per share for the last quarter are -0.02 USD whereas the estimation was -0.04 USD which accounts for 50.00% surprise. Company revenue for the same period amounts to 3.78 M USD despite the estimated figure of 1.03 M USD. Estimated earnings per share for the next quarter are -0.04 USD, and revenue is expected to reach 1.39 M USD. Also watch annual changes over time to get a bigger picture of LCTX earnings per share and revenue dynamics.